1. AHRO : Austin Health Research Online

Thomas John

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Thomas John
Full Name
John, Thomas
 
Variants
John, Tom
 
Department
 
Personal Site
https://www.onjcancercentre.org/profile/a-prof.-tom-john
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  John, Thomas
Subject:  Osimertinib

Results 1-6 of 6 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
12022Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Kim, Sang-We; Kato, Terufumi; Laktionov, Konstantin; Vu, Huu Vinh; Wang, Zhijie; Lu, Shun; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Atasoy, Ajlan; Herbst, Roy S; Tsuboi, Masahiro
21-Dec-2021A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer.Wu, Yi-Long; Tsuboi, Masahiro; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S
3Jan-2020Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA.Brown, Helen; Vansteenkiste, Johan; Nakagawa, Kazuhiko; Cobo, Manuel; John, Thomas ; Barker, Craig; Kohlmann, Alexander; Todd, Alexander; Saggese, Matilde; Chmielecki, Juliann; Markovets, Aleksandra; Scott, Marietta; Ramalingam, Suresh S
49-Oct-2019Brief Report: Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced Non-Small Cell Lung Cancer and Response to Osimertinib versus Comparator in FLAURA.Brown, Helen; Vansteenkiste, Johan; Nakagawa, Kazuhiko; Cobo, Manuel; John, Thomas ; Barker, Craig; Kohlmann, Alexander; Todd, Alexander; Saggese, Matilde; Chmielecki, Juliann; Markovets, Aleksandra; Scott, Marietta; Ramalingam, Suresh S
5Dec-2018EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer.John, Thomas ; Akamatsu, Hiroaki; Delmonte, Angelo; Su, Wu-Chou; Lee, Jong Seok; Chang, Gee-Chen; Huang, Xiangning; Jenkins, Suzanne; Wu, Yi-Long
6Nov-2017Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer.Arulananda, Surein; Do, Hongdo; Musafer, Ashan; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas